May 01, 2019
Article
Despite advances in neurology, a silent epidemic of older adults who sustain a TBI is growing. The authors provide tools and tips for a geriatric approach to treatment.
FDA Extends Review of Omaveloxolone in Friedreich Ataxia
The Wide-Reaching Impact of Multiple Sclerosis DMT Wastes: Darin T. Okuda, MD; Karin Cook
Pepinemab’s Upregulation of SEMA4D Expression Warrants Further Development in Huntington, Alzheimer Disease
Future Relapse Remission in Multiple Sclerosis Impacted by Retinal Layer Thinning